Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOGWOOD: Suprachoroidal CLS-TA for Uveitic Macular Edema
NCT02255032Phase 2Completed
- Sponsor
- Clearside Biomedical
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in macular edema, noninfectious uveitis (NIU), sponsored by Clearside Biomedical. Started Oct 2014; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
macular edemanoninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT02255032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255032.